These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 39039998)

  • 1. Clinicopathologic Dissociation: Robust Lafora Body Accumulation in Malin KO Mice Without Observable Changes in Home-Cage Behavior.
    Krishnan V; Wu J; Mazumder AG; Kamen JL; Schirmer C; Adhyapak N; Bass JS; Lee SC; Maheshwari A; Molinaro G; Gibson JR; Huber KM; Minassian BA
    J Comp Neurol; 2024 Jul; 532(7):e25660. PubMed ID: 39039998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic Dissociation: Robust Lafora Body Accumulation in Malin KO Mice Without Observable Changes in Home-cage Behavior.
    Krishnan V; Wu J; Mazumder AG; Kamen JL; Schirmer C; Adhyapak N; Bass JS; Lee SC; Maheshwari A; Molinaro G; Gibson JR; Huber KM; Minassian BA
    bioRxiv; 2023 Sep; ():. PubMed ID: 37745312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laforin is required for the functional activation of malin in endoplasmic reticulum stress resistance in neuronal cells.
    Zeng L; Wang Y; Baba O; Zheng P; Liu Y; Liu Y
    FEBS J; 2012 Jul; 279(14):2467-78. PubMed ID: 22578008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased laforin and laforin binding to glycogen underlie Lafora body formation in malin-deficient Lafora disease.
    Tiberia E; Turnbull J; Wang T; Ruggieri A; Zhao XC; Pencea N; Israelian J; Wang Y; Ackerley CA; Wang P; Liu Y; Minassian BA
    J Biol Chem; 2012 Jul; 287(30):25650-9. PubMed ID: 22669944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic depletion of the malin E3 ubiquitin ligase in mice leads to lafora bodies and the accumulation of insoluble laforin.
    DePaoli-Roach AA; Tagliabracci VS; Segvich DM; Meyer CM; Irimia JM; Roach PJ
    J Biol Chem; 2010 Aug; 285(33):25372-81. PubMed ID: 20538597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of leptin signaling reduces polyglucosan inclusions and seizure susceptibility in a mouse model for Lafora disease.
    Rai A; Mishra R; Ganesh S
    Hum Mol Genet; 2017 Dec; 26(24):4778-4785. PubMed ID: 28973665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trehalose Ameliorates Seizure Susceptibility in Lafora Disease Mouse Models by Suppressing Neuroinflammation and Endoplasmic Reticulum Stress.
    Sinha P; Verma B; Ganesh S
    Mol Neurobiol; 2021 Mar; 58(3):1088-1101. PubMed ID: 33094475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An inducible glycogen synthase-1 knockout halts but does not reverse Lafora disease progression in mice.
    Nitschke S; Chown EE; Zhao X; Gabrielian S; Petković S; Guisso DR; Perri AM; Wang P; Ahonen S; Nitschke F; Minassian BA
    J Biol Chem; 2021; 296():100150. PubMed ID: 33277363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal glycogen chain length pattern, not hyperphosphorylation, is critical in Lafora disease.
    Nitschke F; Sullivan MA; Wang P; Zhao X; Chown EE; Perri AM; Israelian L; Juana-López L; Bovolenta P; Rodríguez de Córdoba S; Steup M; Minassian BA
    EMBO Mol Med; 2017 Jul; 9(7):906-917. PubMed ID: 28536304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired malin expression and interaction with partner proteins in Lafora disease.
    Skurat AV; Segvich DM; Contreras CJ; Hu YC; Hurley TD; DePaoli-Roach AA; Roach PJ
    J Biol Chem; 2024 May; 300(5):107271. PubMed ID: 38588813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4-Phenylbutyric acid and metformin decrease sensitivity to pentylenetetrazol-induced seizures in a malin knockout model of Lafora disease.
    Sánchez-Elexpuru G; Serratosa JM; Sanz P; Sánchez MP
    Neuroreport; 2017 Mar; 28(5):268-271. PubMed ID: 28181916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laforin prevents stress-induced polyglucosan body formation and Lafora disease progression in neurons.
    Wang Y; Ma K; Wang P; Baba O; Zhang H; Parent JM; Zheng P; Liu Y; Minassian BA; Liu Y
    Mol Neurobiol; 2013 Aug; 48(1):49-61. PubMed ID: 23546741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epm2a
    Burgos DF; Sciaccaluga M; Worby CA; Zafra-Puerta L; Iglesias-Cabeza N; Sánchez-Martín G; Prontera P; Costa C; Serratosa JM; Sánchez MP
    Neurobiol Dis; 2023 Jun; 181():106119. PubMed ID: 37059210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laforin in autophagy: a possible link between carbohydrate and protein in Lafora disease?
    Puri R; Ganesh S
    Autophagy; 2010 Nov; 6(8):1229-31. PubMed ID: 20818153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycogen synthase downregulation rescues the amylopectinosis of murine RBCK1 deficiency.
    Nitschke S; Sullivan MA; Mitra S; Marchioni CR; Lee JPY; Smith BH; Ahonen S; Wu J; Chown EE; Wang P; Petković S; Zhao X; DiGiovanni LF; Perri AM; Israelian L; Grossman TR; Kordasiewicz H; Vilaplana F; Iwai K; Nitschke F; Minassian BA
    Brain; 2022 Jul; 145(7):2361-2377. PubMed ID: 35084461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lafora bodies and neurological defects in malin-deficient mice correlate with impaired autophagy.
    Criado O; Aguado C; Gayarre J; Duran-Trio L; Garcia-Cabrero AM; Vernia S; San Millán B; Heredia M; Romá-Mateo C; Mouron S; Juana-López L; Domínguez M; Navarro C; Serratosa JM; Sanchez M; Sanz P; Bovolenta P; Knecht E; Rodriguez de Cordoba S
    Hum Mol Genet; 2012 Apr; 21(7):1521-33. PubMed ID: 22186026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laforin-malin complex degrades polyglucosan bodies in concert with glycogen debranching enzyme and brain isoform glycogen phosphorylase.
    Liu Y; Zeng L; Ma K; Baba O; Zheng P; Liu Y; Wang Y
    Mol Neurobiol; 2014 Apr; 49(2):645-57. PubMed ID: 24068615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laforin and malin deletions in mice produce similar neurologic impairments.
    García-Cabrero AM; Marinas A; Guerrero R; de Córdoba SR; Serratosa JM; Sánchez MP
    J Neuropathol Exp Neurol; 2012 May; 71(5):413-21. PubMed ID: 22487859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of intracerebroventricular administration of alglucosidase alfa in two mouse models of Lafora disease: Relevance for clinical practice.
    Zafra-Puerta L; Colpaert M; Iglesias-Cabeza N; Burgos DF; Sánchez-Martín G; Gentry MS; Sánchez MP; Serratosa JM
    Epilepsy Res; 2024 Feb; 200():107317. PubMed ID: 38341935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulators of Neuroinflammation Have a Beneficial Effect in a Lafora Disease Mouse Model.
    Mollá B; Heredia M; Sanz P
    Mol Neurobiol; 2021 Jun; 58(6):2508-2522. PubMed ID: 33447969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.